R&D Systems™ Recombinant Human NKp30 Fc Chimera Protein

Catalog No.	Quantity
1849NK025	25 μg

Catalog No. 1849NK025 Supplier R&D Systems™ Supplier No. 1849NK025

Description

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity

Measured by its binding ability in a functional ELISA. When recombinant human B7-H6 Fc Chimera is immobilized at 1 μg/mL (100 μL/well), the concentration of recombinant human NKp30 Fc Chimera that produces 50% of the optimal binding response is found to be approximately 8-40 ng/mL.

Specifications

• Accession Number: Q05D23
• For Use With (Application): Bioactivity
• Formulation: Lyophilized from a 0.2 μm filtered solution in PBS.
• Gene ID (Entrez): 259197
• Molecular Weight (g/mol): M.W. (Observed): 54-60 kDa, reducing conditions; M.W. (theoretical): 40 kDa (monomer)
• Name: NKp30/NCR3 Fc Chimera
• Quantity: 25 μg
• Source: Mouse myeloma cell line, NS0-derived human NKp30/NCR3 protein Human NKp30 (Leu19 - Thr138) (N-terminus) Accession # Q05D23 IEGRMD Human IgG1 (Pro100 - Lys330) (C-terminus)
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20°C to -70°C as supplied. 1 month, 2°C to 8°C under sterile conditions after reconstitution. 3 months, -20°C to -70°C under sterile conditions after reconstitution.
• Structural Form: Disulfide-linked homodimer
• Endotoxin Concentration: <0.10 EU / 1 μg of the protein by the LAL method.
• Gene Symbol: NCR3
• Conjugate: Unconjugated
• Recombinant: Recombinant
• Reconstitution: Reconstitute at 100 μg/mL in sterile PBS.
• Purity or Quality Grade: >90%, by SDS-PAGE under reducing conditions and visualized by silver stain
• Protein: NKp30/NCR3